Prudential Financial Inc Esperion Therapeutics, Inc. Transaction History
Prudential Financial Inc
- $67.5 Billion
- Q1 2025
A detailed history of Prudential Financial Inc transactions in Esperion Therapeutics, Inc. stock. As of the latest transaction made, Prudential Financial Inc holds 26,340 shares of ESPR stock, worth $29,500. This represents 0.0% of its overall portfolio holdings.
Number of Shares
26,340
Previous 33,570
21.54%
Holding current value
$29,500
Previous $73,000
49.32%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding ESPR
# of Institutions
200Shares Held
119MCall Options Held
171KPut Options Held
679K-
Black Rock Inc. New York, NY14MShares$15.7 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.5MShares$12.9 Million0.0% of portfolio
-
Wasatch Advisors Inc Salt Lake City, UT10.9MShares$12.2 Million0.09% of portfolio
-
Bellevue Group Ag Kuesnacht, V89.69MShares$10.9 Million0.32% of portfolio
-
Two Seas Capital LP Rye, NY6.93MShares$7.76 Million0.36% of portfolio
About Esperion Therapeutics, Inc.
- Ticker ESPR
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 66,551,600
- Market Cap $74.5M
- Description
- Esperion Therapeutics, Inc., a pharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low density lipoprotein cholesterol. Its lead product candidates are NEXLETOL (bempedoic acid) and NEXLIZET (bempedoic acid and ezetimibe) tablets for the treatment of patients with atherosclerotic cardiovascul...